Appendix G_HSWLSCTD 2024-006_P and T Committee.pdf

PHARMACY AND THERAPEUTICS

COMMITTEE

HSWLSCTD 2024-006

January 2024

Commanding Officer United States Coast Guard Health, Safety, and Work-Life Service Center

300 E. Main Street Suite 1000 Norfolk, Va. 23510-9109 Staff Symbol: (h) Phone: (757) 628-4787

HSWLSCTD 2024-006

HEALTH, SAFETY AND WORK-LIFE SERVICE CENTER TECHNICAL DIRECTIVE 2024-006

Subj: PHARMACY & THERAPEUTICS COMMITTEE

Ref: (a) Coast Guard Medical Manual, COMDTINST M6000.1 (series)

1. PURPOSE. This publication provides standardized technical directives (TD) issued by the Health, Safety, and Work-Life Service Center (HSWL SC) that addresses the roles and responsibilities, procedures, and guidelines for the CG Pharmacy and Therapeutics Committee (PTC).

2. ACTION. This TD publication applies to all the HSWL SC organizational elements at all types of Coast Guard (CG) units. HSWL SC retains the authority to provide technical direction over all HSWL SC organizational elements. This TD is used to clarify policy that falls under the responsibilities and authorities of the HSWL SC. Internet release is authorized.

3. DIRECTIVES AFFECTED. HSWLSCTD 2018-002 is cancelled.

4. BACKGROUND. COMDTINST M6000.1 (series), ref (a), requires all Coast Guard medical clinics to actively participate in the CG PTC. This committee is now centralized, and Regional Practice PTC meetings are no longer required. This committee shall meet quarterly to review all relevant materials related to the acquisition, use and maintenance of pharmaceuticals within CG units to make informed decisions on necessary changes to policies and procedures therein. These materials may include but are not limited to Defense Health Agency (DHA) changes pertaining to the TRICARE Formulary, MHS Genesis procedures, relevant drug recalls and shortages affecting operations, and updates to clinical guidelines.

a. The provisions of this TD are intended to ensure that the PTC follows and established protocol that has been approved by the Chief of Operational Medicine, and the HSWL SC Pharmacy Consultant.

b. Through the PTC, HSWL-SC shall provide professional oversight to clinics and sickbays.

Specifically, the PTC will establish policies and procedures covering all aspects of pharmaceutical management within the CG. The PTC shall be guided by DHA formulary management policies and will ensure efficient and standardized acquisition, use, and distribution of pharmaceuticals. The PTC is managed by the HSWL SC and supported by Regional Practice sites.

5. DISCLAIMER. This guidance is not a substitute for applicable legal guidance, nor is it itself a rule.

It is intended to provide operational guidance for CG personnel and is not intended to nor does it impose legally binding requirements on any party outside the CG.

6. ENVIRONMENTAL ASPECT AND IMPACT CONSIDERATIONS.

a. The development of this TD and the general policies contained within it have been thoroughly reviewed by the originating office in conjunction with the Office of Environmental Management and are categorically excluded (CE) under current USCG CE #33 from further environmental analysis, in accordance with Section 2.B.2 and Figure 2-1 of the National Environmental Policy Act Implementing Procedures and Policy for Considering Environmental Impacts, COMDTINST M16475.1 (series).

b. This TD will not have any of the following: significant cumulative impacts on the human environment; substantial controversy or substantial change to existing environmental conditions;

or inconsistencies with any Federal, State, or local laws or administrative determinations relating to the environment. All future specific actions resulting from the general policies in this TD must be individually evaluated for compliance with the National Environmental Policy Act (NEPA), Council on Environmental Policy NEPA Regulations at 40 CFR Parts 1500-1508, DHS and CG NEPA policy, and compliance with all other environmental mandates.

7. DISTRIBUTION. No paper distribution will be made of this TD. An electronic version will be located on the CG Portal: https://uscg.sharepoint-mil.us/sites/hswlsc/SitePages/Home.aspx.

8. OVERVIEW.

a. The attached Enclosure(s) contains instructions for, and a listing of required health care materials.

b. Units shall maintain the minimum required quantities listed in the appropriate enclosure. These are only lists of MINIMUM required items and by other items needed to meet specific needs of the unit.

9. PROCEDURES. See Enclosure(s)

10. RECORDS MANAGEMENT CONSIDERATIONS. This TD has been thoroughly reviewed during the directives clearance process and it has been determined there are no further records scheduling requirements, in accordance with Federal Records Act, 44 U.S.C. 3101 et seq., National Archives and Records Administration (NARA) requirements, and the Information and Life Cycle Management Manual, COMDTINST M5212.12 (series). This policy does not have any significant or substantial changes to existing records management requirements.

11. FORMS/REPORTS. None

12. REQUEST FOR CHANGES. Recommendations for improvements to this TD are encouraged and may be submitted by email to HSWLSC OPMED DIVISION utilizing the “Change / Improvement Request to HSAL Afloat” as the subject.

JOSE D. MARTIS

Captain, U.S. Coast Guard Commanding Officer, Health, Safety, & Work-Life Service Center

Encl: (1) PTC Procedures

(2) PTC Memorandum enclosure (1) to HSWLSCTD 2024-006

PHARMACY & THERAPEUTICS COMMITTEE

1. INTRODUCTION.

a. The PTC quorum is composed of pharmacy, medical and administrative personnel from each clinic. The Chairperson shall be the Chief, Operational Medicine (or Deputy) and the Secretary shall be the HSWL SC Pharmacy Consultant (or Deputy or designee). Minutes shall be routed from the Secretary to the Chair for signature after approval from the Committee. PTC minutes shall be constructed in standard memorandum format. Enclosures/attachments may be included as necessary. Meetings may be conducted remotely and/or virtually for efficiency and to account for different clinic schedules and time zones.

2. ROLES AND RESPONSIBILITIES.

a. HSWL SC.

(1) Review PTC TD annually and update as needed.

(2) The Secretary shall organize standard reporting information for inclusion in the PTC minutes. The Secretary shall also write and route the PTC minutes to the Chief, Operational Medicine.

(3) The Chief, Operational Medicine shall serve as the Chair of the Committee and provide support to the Secretary in the execution of the program.

b. RPE.

(1) Support the secretary by facilitating information collection and organization from their respective Areas of Responsibility (AOR) and provide pertinent data as required.

c. Regional Practice Managers.

(1) Ensure that all personnel within the assigned AOR support this program through timely and accurate data collection and transmission; including the items listed below and others as requested.

d. PTC.

(1) Ensure medications and protocols delineated in the CG Standardized Health Services Allowance List (HSAL) are part of the regional practice formulary and guidelines.

(2) Review and approve non-formulary requests as necessary.

(3) Create and review random drug usage evaluations (DUE) for medications that impact clinical practice or readiness standards.

(4) Review Controlled Substance usage and audit reports.

(5) Review pharmacy policies and procedures annually and as necessary.

enclosure (1) to HSWLSCTD 2024-006

(6) Monitor medication related errors and near misses to improve patient safety across the enterprise.

(7) Review Quality Assurance studies and Mishap reports related to pharmaceuticals.

(8) Monitor adverse reaction or product quality reports (i.e., VAERS, MEDWATCH, MMQC drug recalls).

(9) Review pharmacy budget expenditures and forecasts.

(10) Review pharmacy staffing requirements (i.e., “C” school Pharmacy Technician applicants).

(11) Any other topics deemed necessary for PTC review.

e. DOCUMENTATION.

(1) The Secretary shall prepare PTC meeting minutes in CG Standard Memo format (enclosure (2)) and route to the Chairperson for signature.

(2) Minutes are approved virtually utilizing voting applications withing the Microsoft Office Suite. Approved minutes shall be signed and placed in the HSWL SC PTC folder on the CG Portal. Minutes shall be retained for a minimum of 3 years.

f. FORMULARY.

(1) The CG shall follow rules established by the DHA PTC and will utilize the TRICARE Uniform Formulary (UF) as the basis for all formulary determinations within CG medical clinics. The PTC shall review and discuss all relevant quarterly updates published by DHA following PTC meetings enclosure (2) to HSWLSCTD 2024-006

Commanding Officer United States Coast Guard Health, Safety and Work-Life ServiceCenter

Address xxx Address xxx Staff Symbol: h Phone: xxx Fax: xxx Email: xxx@uscg.mil

19 August 2024

MEMORANDUM

From: Secretary, CAPT

HSWL SC Pharmacy Consultant

To: Chairperson, CAPT

Chief, Operational Medicine

Subj: PHARMACY & THERAPEUTICS COMMITTEE MINUTES

Ref: (a) MEDICAL MANUAL, COMDTINST M6000.1 (series)

1. The Pharmacy and Therapeutics Committee meeting convened 05 August 2016, 1300 hours.

2. ATTENDANCE:

3. OLD BUSINESS

a. Item: review of previous minutes: FY24 3rd quarter.

DISCUSSION: previous minutes were electronically accepted.

ACTION: accepted as written.

4. NEW BUSINESS

a. ITEM: high dollar usage list for the quarter.

DISCUSSION:

ACTION:

b. ITEM: high volume usage for the quarter.

c. ITEM:

5. Adjournment Time: 1345 hours.

6. Next Meeting: TBA, October, 2024.

13.

14. Attachments: xxx 15.

Copy: P&T Committee without attachments

CGPORTAL PTC folder QA Chairperson